Healthcare Policies & Innovative Research
Working group 16

Genetic Research

Genetic research in the field of epilepsies is confronted with an extremely large number of new genes, for which the clinical spectrum and/or natural history is often barely known; usually, the number of patients published is limited to a handful, their recruitment may be strongly biased towards a few clinical features, and their clinical description is often limited.

What is this Working Group about?

In a joint effort to promote genetic research, members and non-members of EpiCARE, conveyed into this WG the knowledge and opportunities that have derived by their participation as active members to major concluded and existing EU research networks on epilepsy research in genetics and rare epileptic encephalopathies. To boost the genetic research activities we contributed to the development of a web-platform for patients’ matchmaking, interoperable with other discovery services, based on the RD-NEXUS tool, and provided by the European Joint Project in Rare Disease (EJPRD) to support the wider ERN community. Furthermore, a dedicated webpage offers the possibility to all medical teams to share opportunities of collaborative calls, recruit cohorts of patient carrying rare variants in genes without a well-defined phenotypic spectrum, where single-centre studies would not yield significant series.

ERN-EpiCARE has also joined, as an associated ERN, Solve-RD, a Horizon2020- funded project, dedicated to “solve the unsolved rare diseases”. This will permit the re-analysis of unsolved exomes and genomes of patients with rare developmental and epileptic encephalopathies (DEE) or other rare epilepsy syndromes. Members of the WG regularly contribute to educational webinars focusing on genetic epilepsies, organized by the Education and Training WG. The presentations systematically combine a clinician and a geneticist. When appropriate a patient advocate in also involved. A “training in genetics of the epilepsies” workshop is under preparation.

Leaders

Pr. Gaetan Lesca

Lyon, France

Dr. Simona Balestrini

Florence, Italy

Pr. Renzo Guerrini

Florence, Italy

The main goals

  • Foster research in genetic epilepsies by selecting and promoting EU calls for research grants and facilitate applications, with the support of a dedicated research projects manager.
  • Enable interoperable discovery of patient metadata and core data for identifying clinically or genetically similar clusters.
  • Maintain a collaborative genetic research platform for projects focusing on known gene variants that require further study.
  • Ensure both platforms are public and accessible to all, regardless of ERN EpiCARE membership, encouraging participation from smaller medical teams.
  • Collaborate in the European Rare Diseases Research Alliance 2024–2034 (ERDERA), co-funded by the EU, to further rare disease research efforts.

Core group

Related material and links

June 2025. Salzburg (Austria). Gaetan Lesca. What will be the main actions of the WG in genetic research in the coming 5 years?

In a joint effort to promote genetic research, members and non-members of EpiCARE, conveyed into this WG, together with the one on Clinical Genetics, the knowledge and opportunities that have derived by their participation as active members to major concluded and existing EU research networks on epilepsy research in genetics and rare epileptic encephalopathies, which include:

  1. the FP7 project ‘DESIRE’ (Development and Epilepsy – Strategies for Innovative Research to improve diagnosis, prevention and treatment in children with difficult to treat Epilepsy- grant agreement no. 602531), has provided important contributions to the study of complex and rare epileptic encephalopathies and has collected DNA and brain tissue samples (Pitkänen et al 2019; Blumcke et al 2017), cohorts with rare syndromes, organized databases and clinical trials;
  2. the Epicluster initiative (Henshall et al 2023) of the European Brain Research Area (EBRA), which is subserving a collaborative framework for the coordinated actions of epilepsy research in Europe, based around shared partnerships and research priorities;
  3. the Neuro-MIG European Network on Brain Malformations (CA16118 Funded by the European Cooperation in Science and Technology Action – COST), which has created a powerful international network dedicated to the Genetic diagnosis and management of brain malformations;
  4. the Rare Epilepsy Syndromes (RES) consortium.

If you are interested to voluntarily contribute to this WG activities, please use the contact form to let us know.